Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Sell
12,407
-408
-3% -$21.6K ﹤0.01% 230
2026
Q1
$707K Sell
12,815
-208
-2% -$11.3K 0.01% 204
2025
Q4
$639K Buy
13,023
+985
+8% +$45.9K 0.01% 221
2025
Q3
$520K Buy
+12,038
New +$470K 0.01% 219

Other funds holding GSK

Dynasty Wealth Management's GSK Position: Q2 2026 in Review

Dynasty Wealth Management reduced its GSK (GSK) stake by 3.2% in Q2 2026, selling an estimated $21.6K and leaving 12,407 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Dynasty Wealth Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $707K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Dynasty Wealth Management held 12,407 shares of GSK worth $650K as of Q2 2026.
  • Dynasty Wealth Management sold 408 GSK shares in Q2 2026, an estimated $21.6K.
  • GSK made up ﹤0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #230 holding.
  • Dynasty Wealth Management first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Dynasty Wealth Management's GSK position peaked at $707K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.